Preparation method of compound 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester and febuxostat
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ZHEJIANG AUSUN PHARMA
- Publication Date
- 2016-02-10
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of compound preparation, in particular to a preparation method of the compound 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester and febuxostat. Background technique
[0002] The chemical name of febuxostat is 2-[3-cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid, and its chemical structure is shown in formula (IX):
[0003]
[0004] Febuxostat is a non-purine xanthine oxidase selective inhibitor for the treatment of hyperuricemia in gout patients. Febuxostat inhibits the activity of xanthine oxidase, prevents and reduces the synthesis of uric acid from hypoxanthine or xanthine, so as to achieve the purpose of reducing blood uric acid. Compared with allopurine drugs for the treatment of gout, febuxostat has obvious advantages: first, it has a significant inhibitory effect on xanthine oxidase, and the effect of lowering uric acid is stronger and more durable; second, it will n...